Wood Chemistry Laboratory, Department of Wood Sciences, Université Laval, Québec City, G1V 0A6, Canada; Natural Health Products and Metabolic Diseases Laboratory, Department of Pharmacology and Physiology, Université de Montréal, Montréal, H3C 3J7, Canada; Nutrition and Functional Foods Institute, Université Laval, Québec City, G1V 0A6, Canada.
Natural Health Products and Metabolic Diseases Laboratory, Department of Pharmacology and Physiology, Université de Montréal, Montréal, H3C 3J7, Canada; Nutrition and Functional Foods Institute, Université Laval, Québec City, G1V 0A6, Canada; Department of Pharmacognosy, Beni-Suef Univertsity, Beni-Suef, Egypt.
J Ethnopharmacol. 2019 Dec 5;245:112167. doi: 10.1016/j.jep.2019.112167. Epub 2019 Aug 15.
We recently reported that ethanol extract of Myrianthus arboreus P. Beauv. root bark demonstrated antidiabetic activity by modulating hepatocyte glucose homeostasis. This activity was associated significantly to the ethyl acetate (EAc) fraction. The current study sought to identify the active compounds responsible of the antidiabetic effect of M. arboreus in the EAc fraction using bioassay-directed sub-fractionation.
EAc fraction was sub-fractionated using Flash chromatography. Preparative HPLC was used to isolate the pure compounds. The structures of the isolated compounds were confirmed by analysis of NMR spectroscopic and mass spectrometric data. Hepatic (H4IIE, HepG2) cells were treated with maximum non-toxic concentrations of ethanol extract, its EAc fraction and isolated compounds thereof. Glucose-6-phosphatase (G6Pase) activity was measured using the glucose oxidase method. To measure glycogen synthase (GS) activity, radioactive assays were used. Phosphorylation of AMP-activated protein kinase (AMPK) and Glycogen Synthase Kinase-3 (GSK-3) were probed by Western blot.
Six sub-fractions were obtained, and the antidiabetic activity was found in two sub-fractions (SFE1 and SFE2). For the first time, two known C-glycosylflavone regio-isomers, isoorientin (1) and orientin (2) were detected and isolated from M. arboreus plant, especially from SFE2 as well as protocatechuic acid, 3,4-dihydroxybenzaldehyde (4), and chlorogenic acid isolated from SFE1. The compounds 1, 2, 4 were determined to decrease the activity of G6Pase by increasing AMPK phosphorylation and to stimulate GS through GSK-3 phosphorylation. Isoorientin which is one of the main compounds of EAc fraction, expressed the strongest effect in all bioassays, similar to that of the EAc fraction. A significant and linear correlation was found between the phosphorylation of AMPK and the activity of G6Pase modulated by all samples (R = 0.54; p < 0.05). Similar to G6Pase assay, a correlation was determined between the capacity of M. arboreus extracts/fractions/compounds to stimulate GS activity and to phosphorylate GSK-3 (R = 0.57, p < 0.01).
Results demonstrate that 1, 2, 4 are responsible, at least in part, for the antidiabetic activity of M. arboreus. These compounds can be used to ensure the quality and efficacy of M. arboreus antidiabetic preparations and standardize such preparations.
我们最近报道称,Myrianthus arboreus P. Beauv. 根皮的乙醇提取物通过调节肝细胞葡萄糖稳态表现出抗糖尿病活性。这种活性与乙酸乙酯(EAc)部分显著相关。本研究旨在使用基于生物测定的亚分级分离,从 EAc 部分中鉴定出负责 Myrianthus arboreus 抗糖尿病作用的活性化合物。
使用快速色谱法对 EAc 部分进行亚分级分离。使用制备型 HPLC 分离纯化合物。通过 NMR 光谱和质谱数据分析确认分离化合物的结构。用最大无毒浓度的乙醇提取物、其 EAc 部分和分离的化合物处理肝(H4IIE、HepG2)细胞。使用葡萄糖氧化酶法测量葡萄糖-6-磷酸酶(G6Pase)活性。使用放射性测定法测量糖原合酶(GS)活性。通过 Western blot 探测 AMP 激活的蛋白激酶(AMPK)和糖原合酶激酶-3(GSK-3)的磷酸化。
获得了六个亚馏分,发现两种亚馏分(SFE1 和 SFE2)具有抗糖尿病活性。首次从 Myrianthus arboreus 植物中检测并分离出两种已知的 C-糖苷黄酮区域异构体,异荭草苷(1)和荭草苷(2),特别是从 SFE2 中,以及原儿茶酸、3,4-二羟基苯甲醛(4)和绿原酸从 SFE1 中分离出来。化合物 1、2、4 被确定通过增加 AMPK 磷酸化来降低 G6Pase 的活性,并通过 GSK-3 磷酸化来刺激 GS。异荭草苷是 EAc 部分的主要化合物之一,在所有生物测定中表现出最强的作用,与 EAc 部分相似。发现所有样品调节的 AMPK 磷酸化与 G6Pase 活性之间存在显著的线性相关性(R=0.54;p<0.05)。与 G6Pase 测定一样,还确定了 Myrianthus arboreus 提取物/馏分/化合物刺激 GS 活性和磷酸化 GSK-3 的能力之间存在相关性(R=0.57,p<0.01)。
结果表明,1、2、4 至少部分负责 Myrianthus arboreus 的抗糖尿病活性。这些化合物可用于确保 Myrianthus arboreus 抗糖尿病制剂的质量和功效,并对其进行标准化。